ELITE PHARMACEUTICALS INC /NV/ - COM (ELTP)

Historical Holders from Q1 2014 to Q3 2025

Symbol
ELTP on OTC
Type / Class
Equity / COM
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
5.68K
Holdings value
$3.64K
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
2
Number of buys
1
Average Value change %
+0%
Average buys %
+0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ELITE PHARMACEUTICALS INC /NV/ - COM (ELTP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 5.68K $3.64K +$320 $0.64 2
2025 Q2 5.18K $3.79K $0.73 1
2025 Q1 5.18K $2.25K +$2.25K $0.44 1
2023 Q4 0 $0 -$7.69K 0
2023 Q3 82K $7.69K +$7.69K $0.09 1
2023 Q2 0 $0 -$2.38K 0
2023 Q1 82K $2.38K +$2.38K $0.03 1
2022 Q4 0 $0 -$24K 0
2022 Q3 660K $24K $0 $0.04 2
2022 Q2 660K $29K +$10.3K $0.05 2
2022 Q1 82K $3K $0 $0.04 1
2021 Q4 815K $28K +$3K $0.04 3
2021 Q3 200K $9K -$2K $0.05 1
2021 Q2 249K $12K $0 $0.05 2
2021 Q1 249K $15K $0 $0.06 2
2020 Q4 249K $13K +$10K $0.06 2
2020 Q3 48.8K $3K $0 $0.06 1
2020 Q2 48.8K $4K $0 $0.08 1
2020 Q1 50K $4K $0 $0.08 1
2019 Q4 50K $5K -$9.14K $0.10 1
2019 Q3 159K $13.1K +$4K $0.08 3
2019 Q2 110K $4.64K -$5K $0.04 2
2019 Q1 160K $15.9K +$5K $0.10 3
2018 Q4 110K $8.49K $0 $0.08 2
2018 Q3 110K $10.4K $0 $0.10 2
2018 Q2 110K $10.4K +$5K $0.10 2
2018 Q1 60K $6K $0 $0.10 1
2017 Q4 60K $5.52K -$4K $0.09 1
2017 Q3 100K $10.1K $0 $0.10 2
2017 Q2 501K $94.3K +$9.01K $0.19 3
2017 Q1 453K $66.9K +$8.82K $0.15 3
2016 Q4 393K $60.1K -$1K $0.15 3
2016 Q3 7.5K $1K $0 $0.13 1
2016 Q2 32.5K $10K +$2K $0.29 2
2016 Q1 418K $130K -$1K $0.31 4
2015 Q4 381K $156K +$941 $0.40 4
2015 Q3 0 $0 -$15K 0
2015 Q2 486K $97K $0 $0.20 4
2015 Q1 486K $119K $0 $0.24 4
2014 Q4 511K $116K -$587 $0.23 5
2014 Q3 456K $145K +$12.3K $0.32 4
2014 Q2 415K $176K $0 $0.43 3
2014 Q1 415K $170K +$43.2K $0.41 3